×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RNA – avidity biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/9
08:58 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Medium
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
4/8
09:00 am
rna
Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
High
Report
Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
4/3
10:53 am
rna
Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Low
Report
Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
4/1
09:00 am
rna
Avidity Biosciences to Participate in Upcoming Investor Conference
Medium
Report
Avidity Biosciences to Participate in Upcoming Investor Conference
3/31
04:17 pm
rna
Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy [Yahoo! Finance]
Medium
Report
Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy [Yahoo! Finance]
3/31
09:00 am
rna
Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy
Medium
Report
Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy
3/21
04:05 pm
rna
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/17
01:22 pm
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Medium
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/3
04:56 pm
rna
Form 4 Avidity Biosciences, For: Apr 01 Filed by: Gallagher Kathleen P.
Medium
Report
Form 4 Avidity Biosciences, For: Apr 01 Filed by: Gallagher Kathleen P.
3/25
08:51 am
rna
Form 8-K Avidity Biosciences, For: Mar 19
Medium
Report
Form 8-K Avidity Biosciences, For: Mar 19
3/21
06:44 pm
rna
Form 4 Avidity Biosciences, For: Mar 20 Filed by: Hughes Steven George
Medium
Report
Form 4 Avidity Biosciences, For: Mar 20 Filed by: Hughes Steven George
3/21
06:42 pm
rna
Form 4 Avidity Biosciences, For: Mar 20 Filed by: Boyce Sarah
Medium
Report
Form 4 Avidity Biosciences, For: Mar 20 Filed by: Boyce Sarah
3/21
06:40 pm
rna
Form 4 Avidity Biosciences, For: Mar 20 Filed by: Flanagan W. Michael
Medium
Report
Form 4 Avidity Biosciences, For: Mar 20 Filed by: Flanagan W. Michael
3/21
06:38 pm
rna
Form 4 Avidity Biosciences, For: Mar 20 Filed by: MacLean Michael F
Medium
Report
Form 4 Avidity Biosciences, For: Mar 20 Filed by: MacLean Michael F
3/21
06:36 pm
rna
Form 4 Avidity Biosciences, For: Mar 20 Filed by: McCarthy Teresa
Medium
Report
Form 4 Avidity Biosciences, For: Mar 20 Filed by: McCarthy Teresa
3/17
07:02 am
rna
Form 8-K Avidity Biosciences, For: Mar 17
Medium
Report
Form 8-K Avidity Biosciences, For: Mar 17
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: